November 2014

Eleven Biotherapeutics Announces Additional Financing of $20 MillionFierceBiotechThe investment in Eleven consists of the sale and issuance of 1,743,680 shares of common stock at $11.47 per share, the closing bid price reported by NASDAQ on November 24, 2014, as well as the sale and issuance of warrants to purchase approximately … and more …read more

Eleven Biotherap (EBIO) Reports $20M Securities Purchase AgreementStreetInsider.com (subscription)The investment in Eleven consists of the sale and issuance of 1,743,680 shares of common stock at $11.47 per share, the closing bid price reported by NASDAQ on November 24, 2014, as well as the sale and issuance of warrants to purchase approximately … …read more

Eleven Biotherapeutics Announces Additional Financing of $20 MillionMarketWatchThe investment in Eleven consists of the sale and issuance of 1,743,680 shares of common stock at $11.47 per share, the closing bid price reported by NASDAQ on November 24, 2014, as well as the sale and issuance of warrants to purchase approximately … and more …read more

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of …NasdaqThe warrant transactions will be net share settled upon exercise and could therefore have a dilutive effect with respect to NXP’s common stock to the extent that the market price per share of NXP’s common stock exceeds the strike price of the warrants.

NXP Semiconductors N.V. Announces Pricing of Private Offering of $1 Billion of …CNNMoneyThe warrant transactions will be net share settled upon exercise and could therefore have a dilutive effect with respect to NXP’s common stock to the extent that the market price per share of NXP’s common stock exceeds the strike price of the warrants.